These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28948853)

  • 41. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
    Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
    Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
    Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
    J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus.
    Smart NG; Apelqvist AA; Gu X; Harmon EB; Topper JN; MacDonald RJ; Kim SK
    PLoS Biol; 2006 Feb; 4(2):e39. PubMed ID: 16435884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
    J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus.
    Yan X; Pan J; Xiong W; Cheng M; Sun Y; Zhang S; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):128-36. PubMed ID: 24369345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
    Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
    Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
    Santander C; Brandan E
    Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Smad TGF-beta signals.
    Moustakas A; Heldin CH
    J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
    Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
    Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
    Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
    Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pattern formation in a nonlocal mathematical model for the multiple roles of the TGF-β pathway in tumour dynamics.
    Eftimie R; Perez M; Buono PL
    Math Biosci; 2017 Jul; 289():96-115. PubMed ID: 28511959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.
    Ware TM; Zhu HJ
    EMBO Rep; 2020 Jan; 21(1):e47030. PubMed ID: 31858693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complexity of biological control systems: An autophagy case study.
    Pavel M; Tanasa R; Park SJ; Rubinsztein DC
    Bioessays; 2022 Mar; 44(3):e2100224. PubMed ID: 35032045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A special issue on TGF-β signaling: regulation, crosstalk, and biology.
    Yan X; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):1-2. PubMed ID: 29267839
    [No Abstract]   [Full Text] [Related]  

  • 57. Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.
    Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
    EMBO Rep; 2020 Jan; 21(1):e47269. PubMed ID: 31858684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modelling the dynamics of signalling pathways.
    Sreenath SN; Cho KH; Wellstead P
    Essays Biochem; 2008; 45():1-28. PubMed ID: 18793120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signal integration in TGF-β, WNT, and Hippo pathways.
    Attisano L; Wrana JL
    F1000Prime Rep; 2013; 5():17. PubMed ID: 23755364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crosstalk between TGF-β signaling and epigenome.
    Bai J; Xi Q
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):322. PubMed ID: 29390114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.